(Q48545238)

12 February 2018

title

Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. (English)

1 reference

12 February 2018

author name string

S-C Lee

1

1 reference

12 February 2018

K-Y Lee

2

1 reference

12 February 2018

Y-J Kim

3

1 reference

12 February 2018

S H Kim

4

1 reference

12 February 2018

S-H Koh

5

1 reference

12 February 2018

Y J Lee

6

1 reference

12 February 2018

publication date

29 June 2009

1 reference

12 February 2018

European Journal of Neurology

published in

1 reference

12 February 2018

volume

17

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

45-51

1 reference

12 February 2018

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Dual effects of heparin on VEGF binding to VEGF receptor-1 and transduction of biological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Determinants of prestroke cognitive impairment in stroke associated with small vessel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

Clinical interpretation and use of stroke scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02731.X

10.1111/J.1468-1331.2009.02731.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

19566899

1 reference

12 February 2018